← Browse by Condition
Medical Condition

coronary artery disease

Total Trials
47
Recruiting Now
47
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for coronary artery disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — coronary artery disease Clinical Trials

How many clinical trials are currently recruiting for coronary artery disease?
ClinicalMetric currently tracks 47 actively recruiting clinical trials for coronary artery disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 47. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for coronary artery disease?
coronary artery disease research spans Phase 2 (1 trial), Phase 4 (5 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a coronary artery disease clinical trial?
Eligibility criteria for coronary artery disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
5
Top Sponsors
China National Center for Cardiovascular Diseases 4 trials
Yonsei University 2 trials
Seung-Jung Park 2 trials
Pauls Stradins Clinical University Hospital 2 trials
Peking Union Medical College Hospital 1 trial

Recruiting Clinical Trials

NCT06007248
Recruiting
Disease Characteristics of IR-CAD: a Case-control Study
Enrollment
30 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →
NCT07469397
Recruiting
Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients
Enrollment
157 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT07269366
Recruiting
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
Enrollment
358 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT01524276
Recruiting
Product Surveillance Registry
Enrollment
100,000 pts
Location
United States, Argen...
Sponsor
Medtronic
View Trial →
NCT03497637
Recruiting
Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses
Enrollment
1,054 pts
Location
Germany
Sponsor
Helios Health Institute GmbH
View Trial →
NCT05638867 Phase 4
Recruiting
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
Enrollment
3,944 pts
Location
China
Sponsor
China National Center for Card...
View Trial →
NCT07397845
Recruiting
Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial
Enrollment
1,380 pts
Location
Switzerland
Sponsor
Translumina GmbH
View Trial →
NCT06164457
Recruiting
Implementing Individualized Patient Reported Outcome Measures in Routine Care of Patients With Coronary Artery Disease
Enrollment
200 pts
Location
Canada
Sponsor
University of Calgary
View Trial →
NCT04576130
Recruiting
A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation
Enrollment
1,200 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
View Trial →
NCT07794839
Recruiting
Drug-coated Balloon Treatment
Enrollment
1,000 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul Mehmet Akif Ersoy Edu...
View Trial →
NCT07009418
Recruiting
Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE)
Enrollment
3,500 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →
NCT06489080
Recruiting
Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
Enrollment
10,000 pts
Location
China
Sponsor
Peking University First Hospit...
View Trial →
NCT07476703
Recruiting
Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
Enrollment
1,400 pts
Location
Sweden
Sponsor
Danderyd Hospital
View Trial →
NCT07769008
Recruiting
CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial
Enrollment
826 pts
Location
China
Sponsor
Ruijin Hospital
View Trial →
NCT06567938
Recruiting
Intravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease
Enrollment
1,528 pts
Location
China
Sponsor
First Affiliated Hospital Xi'a...
View Trial →
NCT07635407
Recruiting
QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial
Enrollment
1,472 pts
Location
China
Sponsor
China National Center for Card...
View Trial →
NCT05437965
Recruiting
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
Enrollment
1,000 pts
Location
China
Sponsor
China National Center for Card...
View Trial →
NCT06813534
Recruiting
IVUS Guided PCI in Patients With Chronic Kidney Disease
Enrollment
170 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT06606821 Phase 4
Recruiting
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
Enrollment
124 pts
Location
Denmark
Sponsor
Tina Vilsbøll
View Trial →
NCT05618353 Phase 4
Recruiting
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Enrollment
700 pts
Location
United States
Sponsor
VA Office of Research and Deve...
View Trial →
NCT06917664 Phase 4
Recruiting
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Enrollment
220 pts
Location
China
Sponsor
China National Center for Card...
View Trial →
NCT06863155
Recruiting
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
Enrollment
500 pts
Location
Spain
Sponsor
Fundación EPIC
View Trial →
NCT06567626
Recruiting
Decision Support Tool for Revascularisation Options in Coronary Artery Disease
Enrollment
126 pts
Location
United Kingdom
Sponsor
University of Leicester
View Trial →
NCT06541691
Recruiting
Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease
Enrollment
3,000 pts
Location
Iran
Sponsor
Rajaie Cardiovascular Medical ...
View Trial →
NCT05329285
Recruiting
CABG or PCI in Patients With Ischemic Cardiomyopathy
Enrollment
470 pts
Location
Sweden
Sponsor
Vastra Gotaland Region
View Trial →
NCT05845489 Phase 4
Recruiting
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
Enrollment
11,086 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
View Trial →
NCT06374277
Recruiting
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Enrollment
388 pts
Location
United States
Sponsor
University of Tennessee
View Trial →
NCT07116083
Recruiting
µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
Enrollment
290 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →
NCT05488665
Recruiting
The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique
Enrollment
512 pts
Location
South Korea
Sponsor
Yonsei University
View Trial →
NCT01341327
Recruiting
Observational Study for Left Main Disease Treatment
Enrollment
10,000 pts
Location
China, Malaysia, Sou...
Sponsor
Seung-Jung Park
View Trial →
NCT07771127
Recruiting
HEMOSTATİC PAD AND SANDBAG
Enrollment
480 pts
Location
Turkey (Türkiye)
Sponsor
Uludag University
View Trial →
NCT07485088
Recruiting
Video-based Intervention to Reduce Anxiety in Patients Undergoing Elective PCI
Enrollment
144 pts
Location
Singapore
Sponsor
Tan Tock Seng Hospital
View Trial →
NCT06250790
Recruiting
Selective Coronary Revascularization in Peripheral Artery Disease Patients (SCOREPAD Trial)
Enrollment
600 pts
Location
Latvia
Sponsor
Pauls Stradins Clinical Univer...
View Trial →
NCT02038127
Recruiting
Gangwon PCI Prospective Registry
Enrollment
5,000 pts
Location
South Korea
Sponsor
Yonsei University
View Trial →
NCT04375306
Recruiting
Resting Full-cycle Flow Ratio (RFR) Versus Angiography to Guide Revascularization Strategy in Patients Undergoing Coronary Artery By-pass Grafting (CABG)
Enrollment
500 pts
Location
Belgium, Poland, Slo...
Sponsor
Diagram B.V.
View Trial →
NCT07068399
Recruiting
Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI Perfusion
Enrollment
100 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
View Trial →
NCT04185285
Recruiting
Percutaneous Coronary Intervention Registry FRIBOURG
Enrollment
3,000 pts
Location
Switzerland
Sponsor
University of Freiburg
View Trial →
NCT01838148
Recruiting
Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
Enrollment
4,000 pts
Location
Switzerland
Sponsor
University Hospital, Basel, Sw...
View Trial →
NCT07378163
Recruiting
Study on the Preferences for PCI Implantation Devices Among Doctors and Patients
Enrollment
600 pts
Location
China
Sponsor
Xijing Hospital
View Trial →
NCT06393894
Recruiting
Latvian Early Atherosclerosis Registry
Enrollment
100 pts
Location
Latvia
Sponsor
Pauls Stradins Clinical Univer...
View Trial →
NCT07691502
Recruiting
Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention
Enrollment
200 pts
Location
United States
Sponsor
Minneapolis Heart Institute Fo...
View Trial →
NCT06075602
Recruiting
COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease
Enrollment
5,000 pts
Location
Switzerland
Sponsor
Luzerner Kantonsspital
View Trial →
NCT05427370
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Enrollment
754 pts
Location
United States, Austr...
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →
NCT06820970
Recruiting
CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD
Enrollment
2,000 pts
Location
China
Sponsor
Henan Institute of Cardiovascu...
View Trial →
NCT06302777
Recruiting
MAIN-IMAGE Registry
Enrollment
500 pts
Location
Germany
Sponsor
Goethe University
View Trial →
NCT07118930 Phase 2
Recruiting
Study of Sivelestat Sodium in OPCABG
Enrollment
62 pts
Location
China
Sponsor
Affiliated Hospital of Nantong...
View Trial →
NCT01366404
Recruiting
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
Enrollment
20,000 pts
Location
South Korea
Sponsor
Seung-Jung Park
View Trial →

Related Conditions

percutaneous coronary intervention (4) ischemic heart disease (4) heart failure (2) acute myocardial infarction (2) chronic kidney diseases (2) peripheral arterial disease (2) angina stable (2) coronary artery stenosis (1) coronary artery restenosis (1) coronary artery disease progression (1) inflammation (1) inflammatory disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology